QNTM — Quantum Biopharma Ltd. Class B Subordinate Voting Shares
QNTM (Quantum Biopharma Ltd. Class B Subordinate Voting Shares) stock: $2.10, $17.8M market cap, $1.9M cash, $17.2M EV, $8.7M fully diluted market cap. Data from Fully Diluted's biotech stocks database.
What they do
The Company’s registrar and transfer agent is Marrelli Trust Company Limited. The Company’s agent for service in the United States is CT Company, 28 Liberty Street, New York, New York 10005. For a description of our principal capital expenditures, principal acquisitions and divestitures for the three years ended December 31, 2025, 2024, and 2023 and for those currently in progress, see.
Partnerships University Health Network (UHN License for pharmaceutical-purpose patents/IP associated with Lucid-MS)
Indications
Multiple sclerosis (MS)(Preclinical)
Status note Advancing towards human Phase 2 efficacy trials.
FSD-PEA
Stage not disclosed · Active
Partnerships Epitech (Epitech License Agreement for pharmaceutical-purpose IP associated with FSD-PEA)
Indications
Alcohol misuse(Stage not disclosed)
Status note Product candidate for alcohol misuse in the healthcare area; development stage not disclosed in the filing.
Per-asset detail extracted from the 20-F filed 2026-03-26. Fields the filing does not state are marked "not disclosed" rather than filled from other sources.
No lead program on file for this company.
No active ClinicalTrials.gov trials matched to this company as sponsor or collaborator.
Specialist fund holders
Tracked specialist funds: ADAR1 Capital Management, Aisling Capital, Ally Bridge Group, Avoro Capital Advisors, BVF Partners, Baker Bros. Advisors, Boxer Capital, Braidwell LP, Casdin Capital, Cormorant Asset Management, DAFNA Capital, Deerfield Management, EcoR1 Capital, Frazier Life Sciences, Great Point Partners, Ikarian Capital, Logos Global Management, OrbiMed Advisors, Perceptive Advisors, RA Capital Management, RTW Investments, Sphera Biotech, Stonepine Capital, Tang Capital Partners, Vivo Capital.
None of the tracked specialist funds reported a position in the latest 13F snapshot.
Latest news
Loading headlines…
Headlines from the Fully Diluted live wire: IR newsrooms, newswires, SEC filings, and halt notices, refreshed every 15 minutes.
Get the weekly biotech catalyst rundown. Cash runways, financings, and trial readouts for all 721 stocks.